Novo Nordisk A/S (LON:0TDD)

Novo Nordisk Statistics

Total Valuation

Novo Nordisk has a market cap or net worth of GBP 159.97 billion. The enterprise value is 168.98 billion.

Market Cap	159.97B
Enterprise Value	168.98B

Important Dates

The next estimated earnings date is Wednesday, August 6, 2025.

Earnings Date	Aug 6, 2025
Ex-Dividend Date	Mar 31, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.61%
Shares Change (QoQ)	-0.20%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	3.18B

Valuation Ratios

The trailing PE ratio is 13.64 and the forward PE ratio is 11.93.

PE Ratio	13.64
Forward PE	11.93
PS Ratio	4.71
PB Ratio	10.30
P/TBV Ratio	48.92
P/FCF Ratio	18.03
P/OCF Ratio	10.87
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.24, with an EV/FCF ratio of 19.04.

EV / Earnings	14.40
EV / Sales	4.78
EV / EBITDA	9.24
EV / EBIT	9.86
EV / FCF	19.04

Financial Position

The company has a current ratio of 0.74, with a Debt / Equity ratio of 0.86.

Current Ratio	0.74
Quick Ratio	0.54
Debt / Equity	0.86
Debt / EBITDA	0.76
Debt / FCF	1.50
Interest Coverage	41.95

Financial Efficiency

Return on equity (ROE) is 88.12% and return on invested capital (ROIC) is 47.91%.

Return on Equity (ROE)	88.12%
Return on Assets (ROA)	23.29%
Return on Invested Capital (ROIC)	47.91%
Return on Capital Employed (ROCE)	58.02%
Revenue Per Employee	439,182
Profits Per Employee	151,563
Employee Count	77,349
Asset Turnover	0.77
Inventory Turnover	1.22

Taxes

In the past 12 months, Novo Nordisk has paid 3.11 billion in taxes.

Income Tax	3.11B
Effective Tax Rate	20.93%

Stock Price Statistics

The stock price has decreased by -62.98% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-62.98%
50-Day Moving Average	69.53
200-Day Moving Average	83.38
Relative Strength Index (RSI)	22.04
Average Volume (20 Days)	225,931

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novo Nordisk had revenue of GBP 34.00 billion and earned 11.73 billion in profits. Earnings per share was 2.63.

Revenue	34.00B
Gross Profit	28.78B
Operating Income	16.47B
Pretax Income	14.84B
Net Income	11.73B
EBITDA	17.41B
EBIT	16.47B
Earnings Per Share (EPS)	2.63

Balance Sheet

The company has 4.66 billion in cash and 13.31 billion in debt, giving a net cash position of -8.65 billion.

Cash & Cash Equivalents	4.66B
Total Debt	13.31B
Net Cash	-8.65B
Net Cash Per Share	n/a
Equity (Book Value)	15.54B
Book Value Per Share	3.50
Working Capital	-6.92B

Cash Flow

In the last 12 months, operating cash flow was 14.72 billion and capital expenditures -5.84 billion, giving a free cash flow of 8.87 billion.

Operating Cash Flow	14.72B
Capital Expenditures	-5.84B
Free Cash Flow	8.87B
FCF Per Share	n/a

Margins

Gross margin is 84.65%, with operating and profit margins of 48.43% and 34.51%.

Gross Margin	84.65%
Operating Margin	48.43%
Pretax Margin	43.65%
Profit Margin	34.51%
EBITDA Margin	51.23%
EBIT Margin	48.43%
FCF Margin	26.10%

Dividends & Yields

This stock pays an annual dividend of 0.91, which amounts to a dividend yield of 1.92%.

Dividend Per Share	0.91
Dividend Yield	1.92%
Dividend Growth (YoY)	18.53%
Years of Dividend Growth	8
Payout Ratio	48.61%
Buyback Yield	0.61%
Shareholder Yield	2.53%
Earnings Yield	7.33%
FCF Yield	5.55%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on September 20, 2023. It was a forward split with a ratio of 2.

Last Split Date	Sep 20, 2023
Split Type	Forward
Split Ratio	2

Scores

Novo Nordisk has an Altman Z-Score of 7.88 and a Piotroski F-Score of 5.

Altman Z-Score	7.88
Piotroski F-Score	5